CHICAGO, Illinois, Jan. 19 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its January 2024 edition (Vol. 10, No. 1):

Original Investigation:

* Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial

* First-Line Osimertinib for Previously Untreated Patients . . .

Click here for more information about our products